NASDAQ:PRTO - Nasdaq -
0.8352
+0.19 (+28.45%)
The current stock price of PRTO is 0.8352 null. In the past month the price increased by 161%. In the past year, price decreased by -66.46%.
Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham, Mass.
Proteon Therapeutics Inc.
200 WEST STREET
WALTHAM MA 02451
CEO: Timothy P. Noyes
Phone: 781-890-0102
The current stock price of PRTO is 0.8352 null. The price increased by 28.45% in the last trading session.
The exchange symbol of Proteon Therapeutics Inc. is PRTO and it is listed on the Nasdaq exchange.
PRTO stock is listed on the Nasdaq exchange.
Proteon Therapeutics Inc. (PRTO) has a market capitalization of 18.52M null. This makes PRTO a Nano Cap stock.
Proteon Therapeutics Inc. (PRTO) has a support level at 0.28. Check the full technical report for a detailed analysis of PRTO support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PRTO does not pay a dividend.
Proteon Therapeutics Inc. (PRTO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.96).
ChartMill assigns a technical rating of 7 / 10 to PRTO. When comparing the yearly performance of all stocks, PRTO is one of the better performing stocks in the market, outperforming 97.6% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PRTO. While PRTO seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months PRTO reported a non-GAAP Earnings per Share(EPS) of -0.9600000000000001. The EPS increased by 18.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -193.21% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 73% to PRTO. The Buy consensus is the average rating of analysts ratings from 3 analysts.